{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:38:12Z","timestamp":1789713492247,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T00:00:00Z","timestamp":1469577600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Agency of Scientific and Technological Promotion","award":["FONCYT PICT 2006-01915"],"award-info":[{"award-number":["FONCYT PICT 2006-01915"]}]},{"name":"Grant PIP 2011","award":["166"],"award-info":[{"award-number":["166"]}]},{"DOI":"10.13039\/501100006449","name":"Roemmers Foundation","doi-asserted-by":"crossref","award":["2009-2011"],"award-info":[{"award-number":["2009-2011"]}],"id":[{"id":"10.13039\/501100006449","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008056","name":"Florencio Fiorini Foundation","doi-asserted-by":"crossref","award":["2013"],"award-info":[{"award-number":["2013"]}],"id":[{"id":"10.13039\/100008056","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ren\u00e9 Bar\u00f3n Foundation","award":["2015"],"award-info":[{"award-number":["2015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s13277-016-5268-7","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T23:00:10Z","timestamp":1469574010000},"page":"13377-13384","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Interleukin-6 receptor in spindle-shaped stromal cells, a prognostic determinant of early breast cancer"],"prefix":"10.1007","volume":"37","author":[{"given":"Vivian","family":"Labovsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro Marcelo","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda de Luj\u00e1n","family":"Calcagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin Mauro","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hern\u00e1n","family":"Garc\u00eda-Rivello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Wernicke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Bel\u00e9n","family":"Giorello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayel\u00e9n","family":"Matas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Ra\u00fal","family":"Borzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma Alejandra","family":"Chasseing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,27]]},"reference":[{"key":"5268_CR1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1475-2867-14-41","volume":"14","author":"G Kharaishvili","year":"2014","unstructured":"Kharaishvili G, Simkova D, Bouchalova K, Gachechiladze M, Narsia N, Bouchal J. The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance. Cancer Cell Int. 2014;14:41.","journal-title":"Cancer Cell Int"},{"key":"5268_CR2","doi-asserted-by":"crossref","first-page":"4824573","DOI":"10.1155\/2016\/4824573","volume":"2016","author":"F Cammarota","year":"2016","unstructured":"Cammarota F, Laukkanen MO. Mesenchymal stem\/stromal cells in stromal evolution and cancer progression. Stem Cells Int. 2016;2016:4824573.","journal-title":"Stem Cells Int"},{"key":"5268_CR3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrc1477","volume":"4","author":"MM Mueller","year":"2004","unstructured":"Mueller MM, Fusenig NE. Friends or foes\u2014bipolar effects of the tumour stroma in cancer. Nat Rev Cancer. 2004;4:839\u201349.","journal-title":"Nat Rev Cancer"},{"key":"5268_CR4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.semcancer.2009.05.003","volume":"19","author":"V Baeriswyl","year":"2009","unstructured":"Baeriswyl V, Christofori G. The angiogenic switch in carcinogenesis. Semin Cancer Biol. 2009;19:329\u201337.","journal-title":"Semin Cancer Biol"},{"key":"5268_CR5","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1371\/journal.pbio.0020007","volume":"2","author":"HY Chang","year":"2004","unstructured":"Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, Montgomery K, et al. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol. 2004;2:E7.","journal-title":"PLoS Biol"},{"key":"5268_CR6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/sj.bjc.6604465","volume":"99","author":"AC Dudley","year":"2008","unstructured":"Dudley AC, Shih SC, Cliffe AR, Hida K, Klagsbrun M. Attenuated p53 activation in tumour-associated stromal cells accompanies decreased sensitivity to etoposide and vincristine. Br J Cancer. 2008;99:118\u201325.","journal-title":"Br J Cancer"},{"key":"5268_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-016-0431-5.","author":"A Qiao","year":"2016","unstructured":"Qiao A, Gu F, Guo X, Zhang X, Fu L. Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications. Front Med. 2016. doi: 10.1007\/s11684-016-0431-5.","journal-title":"Front Med"},{"key":"5268_CR8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6:392\u2013401.","journal-title":"Nat Rev Cancer"},{"key":"5268_CR9","doi-asserted-by":"publisher","DOI":"10.14670\/HH-11-700.","author":"YY Jung","year":"2015","unstructured":"Jung YY, Kim HM, Koo JS. The role of cancer-associated fibroblasts in breast cancer pathobiology. Histol Histopathol. 2015. doi: 10.14670\/HH-11-700.","journal-title":"Histol Histopathol"},{"key":"5268_CR10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.canlet.2015.02.018","volume":"361","author":"H Luo","year":"2015","unstructured":"Luo H, Tu G, Liu Z, Liu M. Cancer-associated fibroblasts: a multifaceted driver of breast cancer progression. Cancer Lett. 2015;361:155\u201363.","journal-title":"Cancer Lett"},{"key":"5268_CR11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.semcdb.2009.11.017","volume":"21","author":"G Xouri","year":"2010","unstructured":"Xouri G, Christian S. Origin and function of tumor stroma fibroblasts. Semin Cell Dev Biol. 2010;21:40\u20136.","journal-title":"Semin Cell Dev Biol"},{"key":"5268_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2014.158.","author":"X Sun","year":"2014","unstructured":"Sun X, Mao Y, Wang J, Zu L, Hao M, Cheng G, et al. IL-6 secreted by cancer associated fibroblasts induces tamoxifen resistance in luminal breast cancer. Oncogene. 2014. doi: 10.1038\/onc.2014.158.","journal-title":"Oncogene"},{"key":"5268_CR13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10549-011-1766-x","volume":"133","author":"O Pontiggia","year":"2012","unstructured":"Pontiggia O, Sampayo R, Raffo D, Motter A, Xu R, Bissell MJ, et al. The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through \u03b21 integrin. Breast Cancer Res Treat. 2012;133:459\u201371.","journal-title":"Breast Cancer Res Treat"},{"key":"5268_CR14","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1186\/bcr3224","volume":"14","author":"KL Mueller","year":"2012","unstructured":"Mueller KL, Madden JM, Zoratti GL, Kuperwasser C, List K, Boerner JL. Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met. Breast Cancer Res. 2012;14:R104.","journal-title":"Breast Cancer Res"},{"key":"5268_CR15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semcancer.2014.02.006","volume":"25","author":"J Paulsson","year":"2014","unstructured":"Paulsson J, Micke P. Prognostic relevance of cancer-associated fibroblasts in human cancer. Semin Cancer Biol. 2014;25:61\u20138.","journal-title":"Semin Cancer Biol"},{"key":"5268_CR16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5306\/wjco.v6.i6.207","volume":"6","author":"S Recouvreux","year":"2015","unstructured":"Recouvreux S, Sampayo R, Bessone MI, Simian M. Microenvironment and endocrine resistance in breast cancer: friend or foe? World J Clin Oncol. 2015;6:207\u201311.","journal-title":"World J Clin Oncol"},{"key":"5268_CR17","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1158\/0008-5472.CAN-15-1633","volume":"75","author":"Z Ao","year":"2015","unstructured":"Ao Z, Shah SH, Machlin LM, Parajuli R, Miller PC, Rawal S, et al. Identification of cancer-associated fibroblasts in circulating blood from patients with metastatic breast cancer. Cancer Res. 2015;75:4681\u20137.","journal-title":"Cancer Res"},{"key":"5268_CR18","first-page":"8827","volume":"63","author":"SL Schor","year":"2003","unstructured":"Schor SL, Ellis IR, Jones SJ, Baillie R, Seneviratne K, Clausen J, et al. Migration-stimulating factor: a genetically truncated onco-fetal fibronectin isoform expressed by carcinoma and tumor associated stromal cells. Cancer Res. 2003;63:8827\u201336.","journal-title":"Cancer Res"},{"key":"5268_CR19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1101\/gad.1636908","volume":"22","author":"J Wels","year":"2008","unstructured":"Wels J, Kaplan RN, Rafii S, Lyden D. Migratory neighbors and distant invaders: tumor-associated niche cells. Genes Dev. 2008;22:559\u201374.","journal-title":"Genes Dev"},{"key":"5268_CR20","first-page":"321","volume":"1836","author":"P Barcellos-de-Souza","year":"2013","unstructured":"Barcellos-de-Souza P, Gori V, Bambi F, Chiarugi P. Tumor microenvironment: bone marrow-mesenchymal stem cells as key players. Biochim Biophys Acta. 2013;1836:321\u201335.","journal-title":"Biochim Biophys Acta"},{"key":"5268_CR21","doi-asserted-by":"crossref","first-page":"e68171","DOI":"10.1371\/journal.pone.0068171","volume":"8","author":"AC Monteiro","year":"2013","unstructured":"Monteiro AC, Leal AC, Gon\u00e7alves-Silva T, Mercadante AC, Kestelman F, Chaves SB, et al. T cells induce pre-metastatic osteolytic disease and help bone metastases establishment in a mouse model of metastatic breast cancer. PLoS One. 2013;8:e68171.","journal-title":"PLoS One"},{"key":"5268_CR22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.semcancer.2011.01.002","volume":"21","author":"H Peinado","year":"2011","unstructured":"Peinado H, Lavotshkin S, Lyden D. The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin Cancer Biol. 2011;21:139\u201346.","journal-title":"Semin Cancer Biol"},{"key":"5268_CR23","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.clbc.2014.05.006","volume":"15","author":"V Labovsky","year":"2015","unstructured":"Labovsky V, Martinez LM, Davies KM, Garc\u00eda-Rivello H, Calcagno Mde L, Matas A, et al. Association between ligands and receptors related to the progression of early breast cancer in tumor epithelial and stromal cells. Clin Breast Cancer. 2015;15:e13\u201321.","journal-title":"Clin Breast Cancer"},{"key":"5268_CR24","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1634\/stemcells.2008-0512","volume":"26","author":"P Secchiero","year":"2008","unstructured":"Secchiero P, Melloni E, Corallini F, Beltrami AP, Alviano F, Milani D, et al. Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells. Stem Cells. 2008;26:2955\u201363.","journal-title":"Stem Cells"},{"key":"5268_CR25","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1593\/neo.13706","volume":"15","author":"Q Chang","year":"2013","unstructured":"Chang Q, Bournazou E, Sansone P, Berishaj M, Gao SP, Daly L, et al. The IL-6\/JAK\/Stat3 feed-forward loop drives tumorigenesis and metastasis. Neoplasia. 2013;15:848\u201362.","journal-title":"Neoplasia"},{"key":"5268_CR26","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/nm1107-1289","volume":"13","author":"DR Hurst","year":"2007","unstructured":"Hurst DR, Welch DR. A MSC-ing link in metastasis? Nat Med. 2007;13:1289\u201391.","journal-title":"Nat Med"},{"issue":"Suppl 1","key":"5268_CR27","doi-asserted-by":"crossref","first-page":"i7","DOI":"10.1093\/annonc\/mdi825","volume":"16","author":"BC Pestalozzi","year":"2005","unstructured":"Pestalozzi BC, Luporsi-Gely E, Jost LM, Bergh J, ESMO Guidelines Task Force. ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer. Ann Oncol. 2005;16(Suppl 1):i7\u20139.","journal-title":"Ann Oncol"},{"key":"5268_CR28","doi-asserted-by":"crossref","first-page":"e0121421","DOI":"10.1371\/journal.pone.0121421","volume":"10","author":"LM Martinez","year":"2015","unstructured":"Martinez LM, Labovsky V, Calcagno M d L, Davies KM, Garcia Rivello H, Bianchi MS, et al. CD105 expression on CD34-negative spindle-shaped stromal cells of primary tumor is an unfavorable prognostic marker in early breast cancer patients. PLoS One. 2015;10:e0121421.","journal-title":"PLoS One"},{"key":"5268_CR29","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","volume":"28","author":"ME Hammond","year":"2010","unstructured":"Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology\/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28:2784\u201395.","journal-title":"J Clin Oncol"},{"key":"5268_CR30","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31:3997\u20134013.","journal-title":"J Clin Oncol"},{"key":"5268_CR31","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ccr.2008.03.007","volume":"13","author":"M Hu","year":"2008","unstructured":"Hu M, Yao J, Carroll DK, Weremowicz S, Chen H, Carrasco D, et al. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell. 2008;13:394\u2013406.","journal-title":"Cancer Cell"},{"key":"5268_CR32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10555-012-9415-3","volume":"32","author":"Y Mao","year":"2013","unstructured":"Mao Y, Keller ET, Garfield DH, Shen K, Wang J. Stromal cells in tumor microenvironment and breast cancer. Cancer Metastasis Rev. 2013;32:303\u201315.","journal-title":"Cancer Metastasis Rev"},{"key":"5268_CR33","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10549-010-0855-6","volume":"125","author":"EM Kruijf de","year":"2011","unstructured":"de Kruijf EM, van Nes JG, van de Velde CJ, Putter H, Smit VT, Liefers GJ, et al. Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple negative carcinoma patients. Breast Cancer Res Treat. 2011;125:687\u201396.","journal-title":"Breast Cancer Res Treat"},{"key":"5268_CR34","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1349-7006.2011.01985.x","volume":"102","author":"N Qian","year":"2011","unstructured":"Qian N, Ueno T, Kawaguchi-Sakita N, Kawashima M, Yoshida N, Mikami Y, et al. Prognostic significance of tumor\/stromal caveolin-1 expression in breast cancer patients. Cancer Sci. 2011;102:1590\u20136.","journal-title":"Cancer Sci"},{"key":"5268_CR35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/bjc.2014.279","volume":"111","author":"FJ Gujam","year":"2014","unstructured":"Gujam FJ, Edwards J, Mohammed ZM, Going JJ, McMillan DC. The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer. Br J Cancer. 2014;111:157\u201365.","journal-title":"Br J Cancer"},{"key":"5268_CR36","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12282-010-0234-5","volume":"19","author":"M Yamashita","year":"2012","unstructured":"Yamashita M, Ogawa T, Zhang X, Hanamura N, Kashikura Y, Takamura M, et al. Role of stromal myofibroblasts in invasive breast cancer: stromal expression of \u03b1-smooth muscle actin correlates with worse clinical outcome. Breast Cancer. 2012;19:170\u20136.","journal-title":"Breast Cancer"},{"key":"5268_CR37","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1002\/jcp.22564","volume":"226","author":"F Corallini","year":"2011","unstructured":"Corallini F, Celeghini C, Rimondi E, di Iasio MG, Gonelli A, Secchiero P, et al. Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells. J Cell Physiol. 2011;226:2279\u201386.","journal-title":"J Cell Physiol"},{"key":"5268_CR38","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3892\/or.2015.3721","volume":"33","author":"S Yin","year":"2015","unstructured":"Yin S, Rishi AK, Reddy KB. Anti-estrogen-resistant breast cancer cells are sensitive to cisplatin plus TRAIL treatment. Oncol Rep. 2015;33:1475\u201380.","journal-title":"Oncol Rep"},{"key":"5268_CR39","first-page":"177","volume":"3","author":"K Tawara","year":"2011","unstructured":"Tawara K, Oxford JT, Jorcyk CL. Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies. Cancer Manag Res. 2011;3:177\u201389.","journal-title":"Cancer Manag Res"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-016-5268-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-016-5268-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-016-5268-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T02:07:29Z","timestamp":1589681249000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-016-5268-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,27]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["5268"],"URL":"https:\/\/doi.org\/10.1007\/s13277-016-5268-7","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,27]]}}}